APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cell Banking Outsourcing

A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.

Selected research

Market Analysis & Forecast

Global Cell Banking Outsourcing Market Analysis and Forecast 2026-2032

20 December 2025201 pages

Choose your research edition.

Industry ResearchCell Banking Outsourcing Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Cell Banking Outsourcing Industry Growth and Trends Forecast to 2032114 pages · $3,450 USDMarket StructureGlobal Cell Banking Outsourcing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cell Banking Outsourcing Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Cell Banking Outsourcing Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

A cell bank is a facility that stores cells of specific genome for the purpose of future use in a product or medicinal needs. They often contain expansive amounts of base cell material that can be utilized for various projects. Cell banks can be used to generate detailed characterizations of cell lines and can also help mitigate cross-contamination of a cell line. Utilizing cell banks also reduces the cost of cell culture processes, providing a cost-efficient alternative to keeping cells in culture constantly. Cell banks are commonly used within fields including stem cell research and pharmaceuticals, with cryopreservation being the traditional method of keeping cellular material intact. Cell banks also effectively reduce the frequency of a cell sample diversifying from natural cell divisions over time. Cells mainly used in the regenerative medicine production. Increasing demand of stem cell therapies and number of cell banks expected to boost the global market.

North America is the largest Cell Banking Outsourcing market with about 38% market share. Europe is follower, accounting for about 22% market share.The key manufacturers are SGS Life Sciences, Lonza, CCBC, Vcanbio, AMAG Pharmaceuticals, ViaCord, Thermo Fisher, Wuxi Apptec, CordLife, Esperite, Reliance Life Sciences, Lifecell, Cryo-Cell, Toxikon, Goodwin Biotechnology, Texcell, Cryo Stemcell etc. Top 3 companies occupied about 13% market share.

Report Includes

Read the full market overview

This report presents an overview of global market for Cell Banking Outsourcing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Cell Banking Outsourcing, also provides the revenue of main regions and countries. Of the upcoming market potential for Cell Banking Outsourcing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Cell Banking Outsourcing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Cell Banking Outsourcing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Cell Banking Outsourcing revenue, projected growth trends, production technology, application and end-user industry.

Cell Banking Outsourcing Segment by Company

SGS Life Sciences

Lonza

CCBC

Vcanbio

AMAG Pharmaceuticals

ViaCord

Thermo Fisher

Wuxi Apptec

CordLife

Esperite

Reliance Life Sciences

Lifecell

Cryo-Cell

Toxikon

Goodwin Biotechnology

Texcell

Cryo Stemcell

Cell Banking Outsourcing Segment by Type

Stem Cell Banking

Non-stem Cell Banking

Cell Banking Outsourcing Segment by Application

Cell Bank Storage

Bank Characterization and Testing

Cell Bank Preparation

Cell Banking Outsourcing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Banking Outsourcing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cell Banking Outsourcing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Banking Outsourcing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Cell Banking Outsourcing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Cell Banking Outsourcing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Cell Banking Outsourcing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Cell Banking Outsourcing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Stem Cell Banking Major Player Table 3. Non-stem Cell Banking Major Player Table 4. Global Cell Banking Outsourcing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Cell Bank Storage Major Player Table 6. Bank Characterization and Testing Major Player Table 7. Cell Bank Preparation Major Player Table 8. Cell Banking Outsourcing Industry Trends Table 9. Cell Banking Outsourcing Industry Drivers Table 10. Cell Banking Outsourcing Industry Opportunities and Challenges Table 11. Cell Banking Outsourcing Industry Restraints Table 12. Global Cell Banking Outsourcing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Cell Banking Outsourcing Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Cell Banking Outsourcing Market Share by Region (2021-2026) Table 15. Global Cell Banking Outsourcing Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Cell Banking Outsourcing Market Share by Region (2027-2032) Table 17. Global Cell Banking Outsourcing Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Cell Banking Outsourcing Revenue Market Share by Players (2021-2026) Table 19. Global Cell Banking Outsourcing Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Cell Banking Outsourcing Key Players Headquarters & Area Served Table 21. Global Cell Banking Outsourcing Players, Product Type & Application Table 22. Global Cell Banking Outsourcing Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Cell Banking Outsourcing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Cell Banking Outsourcing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Cell Banking Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Cell Banking Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Cell Banking Outsourcing Revenue Market Share by Type (2021-2026) Table 29. Global Cell Banking Outsourcing Revenue Market Share by Type (2027-2032) Table 30. Global Cell Banking Outsourcing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Cell Banking Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Cell Banking Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Cell Banking Outsourcing Revenue Market Share by Application (2021-2026) Table 34. Global Cell Banking Outsourcing Revenue Market Share by Application (2027-2032) Table 35. SGS Life Sciences Company Information Table 36. SGS Life Sciences Business Overview Table 37. SGS Life Sciences Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. SGS Life Sciences Cell Banking Outsourcing Product Portfolio Table 39. SGS Life Sciences Recent Development Table 40. Lonza Company Information Table 41. Lonza Business Overview Table 42. Lonza Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Lonza Cell Banking Outsourcing Product Portfolio Table 44. Lonza Recent Development Table 45. CCBC Company Information Table 46. CCBC Business Overview Table 47. CCBC Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. CCBC Cell Banking Outsourcing Product Portfolio Table 49. CCBC Recent Development Table 50. Vcanbio Company Information Table 51. Vcanbio Business Overview Table 52. Vcanbio Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Vcanbio Cell Banking Outsourcing Product Portfolio Table 54. Vcanbio Recent Development Table 55. AMAG Pharmaceuticals Company Information Table 56. AMAG Pharmaceuticals Business Overview Table 57. AMAG Pharmaceuticals Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. AMAG Pharmaceuticals Cell Banking Outsourcing Product Portfolio Table 59. AMAG Pharmaceuticals Recent Development Table 60. ViaCord Company Information Table 61. ViaCord Business Overview Table 62. ViaCord Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. ViaCord Cell Banking Outsourcing Product Portfolio Table 64. ViaCord Recent Development Table 65. Thermo Fisher Company Information Table 66. Thermo Fisher Business Overview Table 67. Thermo Fisher Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Thermo Fisher Cell Banking Outsourcing Product Portfolio Table 69. Thermo Fisher Recent Development Table 70. Wuxi Apptec Company Information Table 71. Wuxi Apptec Business Overview Table 72. Wuxi Apptec Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Wuxi Apptec Cell Banking Outsourcing Product Portfolio Table 74. Wuxi Apptec Recent Development Table 75. CordLife Company Information Table 76. CordLife Business Overview Table 77. CordLife Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. CordLife Cell Banking Outsourcing Product Portfolio Table 79. CordLife Recent Development Table 80. Esperite Company Information Table 81. Esperite Business Overview Table 82. Esperite Cell Banking Outsourcing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Esperite Cell Banking Outsourcing Product Portfolio Table 84. Esperite Recent Development Table 85. Reliance Life Sciences Company Information Table 86. Reliance Life Sciences Business Overview Table 87. Reliance Life Sciences Cell Banking Outsourcing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Reliance Life Sciences Cell Banking Outsourcing Product Portfolio Table 89. Reliance Life Sciences Recent Development Table 90. Lifecell Company Information Table 91. Lifecell Business Overview Table 92. Lifecell Cell Banking Outsourcing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Lifecell Cell Banking Outsourcing Product Portfolio Table 94. Lifecell Recent Development Table 95. Cryo-Cell Company Information Table 96. Cryo-Cell Business Overview Table 97. Cryo-Cell Cell Banking Outsourcing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. Cryo-Cell Cell Banking Outsourcing Product Portfolio Table 99. Cryo-Cell Recent Development Table 100. Toxikon Company Information Table 101. Toxikon Business Overview Table 102. Toxikon Cell Banking Outsourcing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 103. Toxikon Cell Banking Outsourcing Product Portfolio Table 104. Toxikon Recent Development Table 105. Goodwin Biotechnology Company Information Table 106. Goodwin Biotechnology Business Overview Table 107. Goodwin Biotechnology Cell Banking Outsourcing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 108. Goodwin Biotechnology Cell Banking Outsourcing Product Portfolio Table 109. Goodwin Biotechnology Recent Development Table 110. Texcell Company Information Table 111. Texcell Business Overview Table 112. Texcell Cell Banking Outsourcing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 113. Texcell Cell Banking Outsourcing Product Portfolio Table 114. Texcell Recent Development Table 115. Cryo Stemcell Company Information Table 116. Cryo Stemcell Business Overview Table 117. Cryo Stemcell Cell Banking Outsourcing Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 118. Cryo Stemcell Cell Banking Outsourcing Product Portfolio Table 119. Cryo Stemcell Recent Development Table 120. North America Cell Banking Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 121. North America Cell Banking Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 122. North America Cell Banking Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 123. North America Cell Banking Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 124. North America Cell Banking Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 125. North America Cell Banking Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 126. North America Cell Banking Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 127. Europe Cell Banking Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 128. Europe Cell Banking Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 129. Europe Cell Banking Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 130. Europe Cell Banking Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 131. Europe Cell Banking Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Europe Cell Banking Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 133. Europe Cell Banking Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 134. China Cell Banking Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 135. China Cell Banking Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 136. China Cell Banking Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 137. China Cell Banking Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 138. Asia Cell Banking Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 139. Asia Cell Banking Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 140. Asia Cell Banking Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 141. Asia Cell Banking Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 142. Asia Cell Banking Outsourcing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 143. Asia Cell Banking Outsourcing Revenue by Region (US$ Million) & (2021-2026) Table 144. Asia Cell Banking Outsourcing Revenue by Region (US$ Million) & (2027-2032) Table 145. SAMEA Cell Banking Outsourcing Revenue by Type (2021-2026) & (US$ Million) Table 146. SAMEA Cell Banking Outsourcing Revenue by Type (2027-2032) & (US$ Million) Table 147. SAMEA Cell Banking Outsourcing Revenue by Application (2021-2026) & (US$ Million) Table 148. SAMEA Cell Banking Outsourcing Revenue by Application (2027-2032) & (US$ Million) Table 149. SAMEA Cell Banking Outsourcing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 150. SAMEA Cell Banking Outsourcing Revenue by Country (2021-2026) & (US$ Million) Table 151. SAMEA Cell Banking Outsourcing Revenue by Country (US$ Million) & (2027-2032) Table 152. Research Programs/Design for This Report Table 153. Authors List of This Report Table 154. Secondary Sources Table 155. Primary Sources List of Figures Figure 1. Cell Banking Outsourcing Image Figure 2. Global Cell Banking Outsourcing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cell Banking Outsourcing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Stem Cell Banking Image Figure 5. Non-stem Cell Banking Image Figure 6. Global Cell Banking Outsourcing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Cell Banking Outsourcing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Cell Bank Storage Image Figure 9. Bank Characterization and Testing Image Figure 10. Cell Bank Preparation Image Figure 11. Global Cell Banking Outsourcing Market Size (US$ Million) & (2021-2032) Figure 12. Global Cell Banking Outsourcing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Cell Banking Outsourcing Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Cell Banking Outsourcing Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Cell Banking Outsourcing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Cell Banking Outsourcing Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Cell Banking Outsourcing Revenue Market Share by Type (2021-2032) Figure 19. Global Cell Banking Outsourcing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Cell Banking Outsourcing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Cell Banking Outsourcing Revenue Market Share by Application (2021-2032) Figure 22. North America Cell Banking Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Cell Banking Outsourcing Revenue Share by Type (2021-2032) Figure 24. North America Cell Banking Outsourcing Revenue Share by Application (2021-2032) Figure 25. North America Cell Banking Outsourcing Revenue Share by Country (2021-2032) Figure 26. United States Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Cell Banking Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Cell Banking Outsourcing Revenue Share by Type (2021-2032) Figure 31. Europe Cell Banking Outsourcing Revenue Share by Application (2021-2032) Figure 32. Europe Cell Banking Outsourcing Revenue Share by Country (2021-2032) Figure 33. Germany Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Cell Banking Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Cell Banking Outsourcing Revenue Share by Type (2021-2032) Figure 43. China Cell Banking Outsourcing Revenue Share by Application (2021-2032) Figure 44. Asia Cell Banking Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Cell Banking Outsourcing Revenue Share by Type (2021-2032) Figure 46. Asia Cell Banking Outsourcing Revenue Share by Application (2021-2032) Figure 47. Asia Cell Banking Outsourcing Revenue Share by Region (2021-2032) Figure 48. Japan Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Cell Banking Outsourcing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Cell Banking Outsourcing Revenue Share by Type (2021-2032) Figure 56. SAMEA Cell Banking Outsourcing Revenue Share by Application (2021-2032) Figure 57. SAMEA Cell Banking Outsourcing Revenue Share by Country (2021-2032) Figure 58. Brazil Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Cell Banking Outsourcing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Stem Cell Banking
  • Non-stem Cell Banking
Applications
  • Cell Bank Storage
  • Bank Characterization and Testing
  • Cell Bank Preparation
Companies covered
  • SGS Life Sciences
  • Lonza
  • CCBC
  • Vcanbio
  • AMAG Pharmaceuticals
  • ViaCord
  • Thermo Fisher
  • Wuxi Apptec
  • CordLife
  • Esperite
  • Reliance Life Sciences
  • Lifecell
  • Cryo-Cell
  • Toxikon
  • Goodwin Biotechnology
  • Texcell
  • Cryo Stemcell

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Cell Banking Outsourcing Market by Type
  3. 1.2.1 Global Cell Banking Outsourcing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Stem Cell Banking
  5. 1.2.3 Non-stem Cell Banking
  6. 1.3 Cell Banking Outsourcing Market by Application
  7. 1.3.1 Global Cell Banking Outsourcing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Cell Bank Storage
  9. 1.3.3 Bank Characterization and Testing
  10. 1.3.4 Cell Bank Preparation
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Cell Banking Outsourcing Market Dynamics
  1. 2.1 Cell Banking Outsourcing Industry Trends
  2. 2.2 Cell Banking Outsourcing Industry Drivers
  3. 2.3 Cell Banking Outsourcing Industry Opportunities and Challenges
  4. 2.4 Cell Banking Outsourcing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Cell Banking Outsourcing Market Perspective (2021-2032)
  2. 3.2 Global Cell Banking Outsourcing Growth Trends by Region
  3. 3.2.1 Global Cell Banking Outsourcing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Cell Banking Outsourcing Market Size by Region (2021-2026)
  5. 3.2.3 Global Cell Banking Outsourcing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Cell Banking Outsourcing Revenue by Players
  2. 4.1.1 Global Cell Banking Outsourcing Revenue by Players (2021-2026)
  3. 4.1.2 Global Cell Banking Outsourcing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Cell Banking Outsourcing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Cell Banking Outsourcing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Cell Banking Outsourcing Key Players Headquarters & Area Served
  7. 4.4 Global Cell Banking Outsourcing Players, Product Type & Application
  8. 4.5 Global Cell Banking Outsourcing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Cell Banking Outsourcing Market CR5 and HHI
  11. 4.6.3 2025 Cell Banking Outsourcing Tier 1, Tier 2, and Tier 3
5 Cell Banking Outsourcing Market Size by Type
  1. 5.1 Global Cell Banking Outsourcing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Cell Banking Outsourcing Revenue by Type (2021-2032)
  3. 5.3 Global Cell Banking Outsourcing Revenue Market Share by Type (2021-2032)
6 Cell Banking Outsourcing Market Size by Application
  1. 6.1 Global Cell Banking Outsourcing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Cell Banking Outsourcing Revenue by Application (2021-2032)
  3. 6.3 Global Cell Banking Outsourcing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 SGS Life Sciences
  2. 7.1.1 SGS Life Sciences Company Information
  3. 7.1.2 SGS Life Sciences Business Overview
  4. 7.1.3 SGS Life Sciences Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 SGS Life Sciences Cell Banking Outsourcing Product Portfolio
  6. 7.1.5 SGS Life Sciences Recent Developments
  7. 7.2 Lonza
  8. 7.2.1 Lonza Company Information
  9. 7.2.2 Lonza Business Overview
  10. 7.2.3 Lonza Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Lonza Cell Banking Outsourcing Product Portfolio
  12. 7.2.5 Lonza Recent Developments
  13. 7.3 CCBC
  14. 7.3.1 CCBC Company Information
  15. 7.3.2 CCBC Business Overview
  16. 7.3.3 CCBC Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 CCBC Cell Banking Outsourcing Product Portfolio
  18. 7.3.5 CCBC Recent Developments
  19. 7.4 Vcanbio
  20. 7.4.1 Vcanbio Company Information
  21. 7.4.2 Vcanbio Business Overview
  22. 7.4.3 Vcanbio Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Vcanbio Cell Banking Outsourcing Product Portfolio
  24. 7.4.5 Vcanbio Recent Developments
  25. 7.5 AMAG Pharmaceuticals
  26. 7.5.1 AMAG Pharmaceuticals Company Information
  27. 7.5.2 AMAG Pharmaceuticals Business Overview
  28. 7.5.3 AMAG Pharmaceuticals Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 AMAG Pharmaceuticals Cell Banking Outsourcing Product Portfolio
  30. 7.5.5 AMAG Pharmaceuticals Recent Developments
  31. 7.6 ViaCord
  32. 7.6.1 ViaCord Company Information
  33. 7.6.2 ViaCord Business Overview
  34. 7.6.3 ViaCord Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 ViaCord Cell Banking Outsourcing Product Portfolio
  36. 7.6.5 ViaCord Recent Developments
  37. 7.7 Thermo Fisher
  38. 7.7.1 Thermo Fisher Company Information
  39. 7.7.2 Thermo Fisher Business Overview
  40. 7.7.3 Thermo Fisher Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Thermo Fisher Cell Banking Outsourcing Product Portfolio
  42. 7.7.5 Thermo Fisher Recent Developments
  43. 7.8 Wuxi Apptec
  44. 7.8.1 Wuxi Apptec Company Information
  45. 7.8.2 Wuxi Apptec Business Overview
  46. 7.8.3 Wuxi Apptec Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Wuxi Apptec Cell Banking Outsourcing Product Portfolio
  48. 7.8.5 Wuxi Apptec Recent Developments
  49. 7.9 CordLife
  50. 7.9.1 CordLife Company Information
  51. 7.9.2 CordLife Business Overview
  52. 7.9.3 CordLife Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 CordLife Cell Banking Outsourcing Product Portfolio
  54. 7.9.5 CordLife Recent Developments
  55. 7.10 Esperite
  56. 7.10.1 Esperite Company Information
  57. 7.10.2 Esperite Business Overview
  58. 7.10.3 Esperite Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Esperite Cell Banking Outsourcing Product Portfolio
  60. 7.10.5 Esperite Recent Developments
  61. 7.11 Reliance Life Sciences
  62. 7.11.1 Reliance Life Sciences Company Information
  63. 7.11.2 Reliance Life Sciences Business Overview
  64. 7.11.3 Reliance Life Sciences Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Reliance Life Sciences Cell Banking Outsourcing Product Portfolio
  66. 7.11.5 Reliance Life Sciences Recent Developments
  67. 7.12 Lifecell
  68. 7.12.1 Lifecell Company Information
  69. 7.12.2 Lifecell Business Overview
  70. 7.12.3 Lifecell Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Lifecell Cell Banking Outsourcing Product Portfolio
  72. 7.12.5 Lifecell Recent Developments
  73. 7.13 Cryo-Cell
  74. 7.13.1 Cryo-Cell Company Information
  75. 7.13.2 Cryo-Cell Business Overview
  76. 7.13.3 Cryo-Cell Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Cryo-Cell Cell Banking Outsourcing Product Portfolio
  78. 7.13.5 Cryo-Cell Recent Developments
  79. 7.14 Toxikon
  80. 7.14.1 Toxikon Company Information
  81. 7.14.2 Toxikon Business Overview
  82. 7.14.3 Toxikon Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Toxikon Cell Banking Outsourcing Product Portfolio
  84. 7.14.5 Toxikon Recent Developments
  85. 7.15 Goodwin Biotechnology
  86. 7.15.1 Goodwin Biotechnology Company Information
  87. 7.15.2 Goodwin Biotechnology Business Overview
  88. 7.15.3 Goodwin Biotechnology Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Goodwin Biotechnology Cell Banking Outsourcing Product Portfolio
  90. 7.15.5 Goodwin Biotechnology Recent Developments
  91. 7.16 Texcell
  92. 7.16.1 Texcell Company Information
  93. 7.16.2 Texcell Business Overview
  94. 7.16.3 Texcell Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Texcell Cell Banking Outsourcing Product Portfolio
  96. 7.16.5 Texcell Recent Developments
  97. 7.17 Cryo Stemcell
  98. 7.17.1 Cryo Stemcell Company Information
  99. 7.17.2 Cryo Stemcell Business Overview
  100. 7.17.3 Cryo Stemcell Cell Banking Outsourcing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Cryo Stemcell Cell Banking Outsourcing Product Portfolio
  102. 7.17.5 Cryo Stemcell Recent Developments
8 North America
  1. 8.1 North America Cell Banking Outsourcing Revenue (2021-2032)
  2. 8.2 North America Cell Banking Outsourcing Revenue by Type (2021-2032)
  3. 8.2.1 North America Cell Banking Outsourcing Revenue by Type (2021-2026)
  4. 8.2.2 North America Cell Banking Outsourcing Revenue by Type (2027-2032)
  5. 8.3 North America Cell Banking Outsourcing Revenue Share by Type (2021-2032)
  6. 8.4 North America Cell Banking Outsourcing Revenue by Application (2021-2032)
  7. 8.4.1 North America Cell Banking Outsourcing Revenue by Application (2021-2026)
  8. 8.4.2 North America Cell Banking Outsourcing Revenue by Application (2027-2032)
  9. 8.5 North America Cell Banking Outsourcing Revenue Share by Application (2021-2032)
  10. 8.6 North America Cell Banking Outsourcing Revenue by Country
  11. 8.6.1 North America Cell Banking Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Cell Banking Outsourcing Revenue by Country (2021-2026)
  13. 8.6.3 North America Cell Banking Outsourcing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Cell Banking Outsourcing Revenue (2021-2032)
  2. 9.2 Europe Cell Banking Outsourcing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Cell Banking Outsourcing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Cell Banking Outsourcing Revenue by Type (2027-2032)
  5. 9.3 Europe Cell Banking Outsourcing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Cell Banking Outsourcing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Cell Banking Outsourcing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Cell Banking Outsourcing Revenue by Application (2027-2032)
  9. 9.5 Europe Cell Banking Outsourcing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Cell Banking Outsourcing Revenue by Country
  11. 9.6.1 Europe Cell Banking Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Cell Banking Outsourcing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Cell Banking Outsourcing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Cell Banking Outsourcing Revenue (2021-2032)
  2. 10.2 China Cell Banking Outsourcing Revenue by Type (2021-2032)
  3. 10.2.1 China Cell Banking Outsourcing Revenue by Type (2021-2026)
  4. 10.2.2 China Cell Banking Outsourcing Revenue by Type (2027-2032)
  5. 10.3 China Cell Banking Outsourcing Revenue Share by Type (2021-2032)
  6. 10.4 China Cell Banking Outsourcing Revenue by Application (2021-2032)
  7. 10.4.1 China Cell Banking Outsourcing Revenue by Application (2021-2026)
  8. 10.4.2 China Cell Banking Outsourcing Revenue by Application (2027-2032)
  9. 10.5 China Cell Banking Outsourcing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Cell Banking Outsourcing Revenue (2021-2032)
  2. 11.2 Asia Cell Banking Outsourcing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Cell Banking Outsourcing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Cell Banking Outsourcing Revenue by Type (2027-2032)
  5. 11.3 Asia Cell Banking Outsourcing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Cell Banking Outsourcing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Cell Banking Outsourcing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Cell Banking Outsourcing Revenue by Application (2027-2032)
  9. 11.5 Asia Cell Banking Outsourcing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Cell Banking Outsourcing Revenue by Country
  11. 11.6.1 Asia Cell Banking Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Cell Banking Outsourcing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Cell Banking Outsourcing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Cell Banking Outsourcing Revenue (2021-2032)
  2. 12.2 SAMEA Cell Banking Outsourcing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Cell Banking Outsourcing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Cell Banking Outsourcing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Cell Banking Outsourcing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Cell Banking Outsourcing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Cell Banking Outsourcing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Cell Banking Outsourcing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Cell Banking Outsourcing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Cell Banking Outsourcing Revenue by Country
  11. 12.6.1 SAMEA Cell Banking Outsourcing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Cell Banking Outsourcing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Cell Banking Outsourcing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst